An interventional study of Distal rectus femoris transfer in Cerebral Palsy, sponsored by Heidelberg University. Completed at 1 site in Germany. Open to participants aged 6 Years to 16 Years. Per ClinicalTrials.gov, last updated 2011-07-11.
Sponsored by Heidelberg University · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the effects of an additional distal rectus femoris transfer carried out as a part of single-event multilevel surgery in children with spastic diplegic cerebral palsy.
1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.
This study's enrollment of 36 is close to the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Heidelberg University is the lead sponsor of 279 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Single-event multilevel surgery with a concomitant distal rectus femoris transfer
Procedure: Distal rectus femoris transfer
Single-event multilevel surgery without distal rectus femoris transfer
Transfer of the distal rectus femoris tendon to the semitendinosus tendon.
Also known as: rectus tendon transfer, rectus femoris transfer, rectus transposition
Range of knee flexion in swing phase
Time frame: prior intervention (baseline) and 1 year post intervention
Peak knee flexion in swing phase
Time frame: prior to intervention (basline) and 1 year post intervention
This study is completed, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heidelberg University